(Q41091905)

26 September 2017

Mechanism of action of T-705 against influenza virus (English)

1 reference

26 September 2017

1 reference

Yousuke Furuta

1

1 reference

26 September 2017

Kazumi Takahashi

2

1 reference

26 September 2017

Masako Kuno-Maekawa

3

1 reference

26 September 2017

Hidehiro Sangawa

4

1 reference

26 September 2017

Sayuri Uehara

5

1 reference

26 September 2017

Kyo Kozaki

6

1 reference

26 September 2017

Nobuhiko Nomura

7

1 reference

26 September 2017

Hiroyuki Egawa

8

1 reference

26 September 2017

Kimiyasu Shiraki

9

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Antimicrobial Agents and Chemotherapy

26 September 2017

1 reference

26 September 2017

49

1 reference

26 September 2017

3

1 reference

26 September 2017

981-986

1 reference

Spotlight on zanamivir in influenza

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

In vitro and in vivo activities of anti-influenza virus compound T-705.

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Inhibition of Borna disease virus replication by ribavirin

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Serious morbidity and mortality associated with influenza epidemics

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Ribavirin: a clinical overview

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Anti-influenza virus activity of the compound LY253963

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Inhibition of the Replication of Influenza A and B Viruses by a Nucleoside Analogue (Ribavirin)

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

In vitro and in vivo activities of T-705 and oseltamivir against influenza virus

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549233

Mycophenolic acid: antiviral and antitumor properties

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15728892

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.49.3.981-986.2005

1 reference

26 September 2017

1 reference

26 September 2017

PubMed publication ID

15728892

1 reference